Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of aberrant circulating mi RNA s in Parkinson's disease plasma samples

19 Feb 2018

Abstract excerpt

Objective: To detect the aberrant expression of circulating miRNAs and explore the potential early diagnostic biomarkers in patients with Parkinson's disease (PD). Methods: Plasma samples were collected from 25 treatment-naïve PD-diagnosed patients and 25 healthy controls followed by a real-time PCR-based miRNA screening analysis of neuron disease-related miRNAs. Results: A subset of miRNAs with aberrant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Nuclear Receptors and Signaling
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29670823
DOI: 10.1002/brb3.941

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of aberrant circulating mi RNA s in Parkinson's disease plasma samplesPMID 29670823Read ↗

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson’s DiseaseSemantic proximity Read ↗

Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson’s diseaseSemantic proximity Read ↗

Circulating Inflammatory miRNAs Associated with Parkinson’s Disease PathophysiologySemantic proximity Read ↗

Plasma miRNA Biomarker Signatures in Parkinsonian SyndromesSemantic proximity Read ↗

A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s diseaseSemantic proximity Read ↗

Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controlsSemantic proximity Read ↗

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative DiseasesSemantic proximity Read ↗

Identification of blood serum micro‐RNAs associated with idiopathic and LRRK2 Parkinson's diseaseSemantic proximity Read ↗

Identification of a panel of five serum miRNAs as a biomarker for Parkinson's diseaseSemantic proximity Read ↗

Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseSemantic proximity Read ↗

Serum Exosomal miRNAs as Biomarkers of Early Diagnosis and Progression in Parkinson's DiseaseSemantic proximity Read ↗

Validation of differentially expressed brain‐enriched microRNAs in the plasma of PD patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.